FH Calculator

Q: お住まいの国では利用できないFH Calculatorをダウンロードしたい時にはどうすればいい？

<a href="https://apkpure.com/howto/how-to-download-an-iphone-app-if-it-is-not-available-in-your-country">ここ</a>をクリック！地理的に制限されているアプリのダウンロード方法をご参考ください。

Q: FH Calculatorの対応言語は何ですか？

FH Calculatorは次の言語がサポートされています。 英語

Q: FH Calculatorを実行するための最小システム要件は何？

次のリストをチェックして、FH Calculatorの最低システム要件をご確認ください。<br/><ul><li>iPhone-iOS 6.0以降が必要です。</li><li>iPad-iPadOS 6.0以降が必要です。</li><li>iPod touch-iOS 6.0以降が必要です。</li></ul>

無料

1.0for iPhone, iPad and more

Alphabit S.A.

Developer

11MB

Size

2015年06月17日

Update Date

Health & Fitness

Category

Age Rating

App Store 開発者ウェブサイト

Age Rating

Apps in this category do not contain restricted content.

Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

FH Calculator スクリーンショット

iPad

iPhone

About FH Calculator

Heterozygous familial hypercholesterolemia (FH) is the most common inherited metabolic disease causing lifelong elevated serum cholesterol levels. Despite affecting over 10 million individuals worldwide, most carriers are either under treated or mistreated and thus suffer from preventable coronary heart disease. This app will help the individuals learn about FH and the clinicians diagnose their patients. Once diagnosed and treated, the individuals with FH have the same risk of cardiovascular disease as the general population after 10 years of treatment.
The application is sponsored by the Hellenic Atherosclerosis Society (HAS). HAS is a Hellenic non-profit scientific organization which promotes research and education in the field of atherosclerosis and help all its members evolve their scientific knowledge and skills. The official journal of HAS is the Hellenic Journal of Atherosclerosis (www.atherosclerosis.gr).